{'output': [['sterna biologicals GmbH & Co. KG', 'ORG', 'Announce', 'Company', 'ORG'], ['sterna biologicals GmbH & Co. KG', 'ORG', 'Appoint', 'Christian M. Pangratz', 'PERSON'], ['Christian M. Pangratz', 'PERSON', 'Bring', 'over 25 years of life sciences experience', 'CONCEPT'], ['Christian M. Pangratz', 'PERSON', 'Participates_In', 'number of successful business transformations', 'CONCEPT'], ['Christian M. Pangratz', 'PERSON', 'Participates_In', 'high-value transactions across various therapeutic areas', 'CONCEPT'], ['Jonas Renz', 'PERSON', 'Managing Director', 'of sterna biologicals GmbH & Co. KG', 'ORG'], ['Christian Pangratz', 'PERSON', 'Work_With', 'sterna team', 'ORG'], ['sterna biologicals GmbH & Co. KG', 'ORG', 'Operate_In', 'clinical-stage immunology company', 'ORG'], ['sterna biologicals GmbH & Co. KG', 'ORG', 'Develop', 'novel treatments for chronic inflammatory diseases', 'CONCEPT'], ['sterna biologicals GmbH & Co. KG', 'ORG', 'Target', 'transcription factors', 'CONCEPT'], ['sterna biologicals GmbH & Co. KG', 'ORG', 'Have', 'four programs in Phase II development', 'CONCEPT']]}